GeneDx
Steve McMillan currently serves as Head of Operational Finance at GeneDx, overseeing budgeting, forecasting, long-term planning, internal management reporting, and financial systems since May 2022. Prior to this role, Steve held the position of Senior Director of Financial Planning and Analysis at BioReference Laboratories, where significant contributions included implementing a Qlik application for comprehensive financial analysis. Steve's career also features various managerial roles at American Standard Brands and inVentiv Health Clinical, focusing on financial systems, operational management, and financial planning. Steve McMillan holds a Master's degree in Accountancy and a Bachelor of Science in Business Administration from Rider University.
This person is not in any teams
This person is not in any offices
GeneDx
10 followers
GeneDx is focused on delivering personalized, actionable insights that improve health outcomes. We sit at the intersection of diagnostics and data science, pairing decades of genomic expertise with an unmatched ability to interpret clinical data at scale. Our exome and genome testing is among the best in the industry. We expect that it will be even more advanced in the future with the help of Centrellis®, our innovative health information platform. Powered by millions of medical records, Centrellis® integrates digital tools with artificial intelligence to ingest and synthesize clinical and genomic data. As a result of our robust test menu, including our exome and genome testing, and the comprehensive insights generated by Centrellis®, we are developing a more complete understanding of complex disease than ever before. This translates to faster diagnosis, more effective treatment plans, and enhanced drug discovery. Our offerings help a whole spectrum of healthcare partners -- clinicians, researchers, health systems, pharmaceutical companies, and payors -- improve patient experiences and advance population health.